Copper binding is not just a contest between two isolated molecules. Other ligands and the experimental environment can change the distribution of metal-containing species. Primary study
What was reported
The 1981 study examined copper–GHK chemistry with and without histidine using titration and visible spectroscopy. Multiple solution species were detected, including ternary complexes when histidine was present. Equilibrium-dialysis experiments showed competition with albumin under specified laboratory conditions. The investigators discussed possible physiological implications rather than directly demonstrating delivery into human tissues. Primary report
Our appraisal: concentration and temperature belong beside a binding claim
An equilibrium distribution depends on the amounts and affinities of all relevant participants. A result obtained with equal concentrations of two binding partners cannot simply be transferred to a setting where their concentrations are very different.
Experimental conditions also matter. Temperature, pH, ionic environment, and competing molecules can influence the measured distribution. A statement that one ligand “takes copper from” another loses important meaning if it omits the conditions under which the comparison was made.
Ternary complexes add another layer. A metal may interact with more than one ligand within the same species, so the system cannot always be represented as a simple binary choice. This is one reason a total copper measurement does not necessarily identify the molecular form carrying it.
Finally, equilibrium binding is not the same as a transport experiment. Establishing movement into cells or tissues requires appropriate uptake, localization, and time-course measurements. A plausible physiological interpretation is a hypothesis to test, not a measured clinical outcome.
The study is valuable as an early examination of competing interactions in copper–peptide chemistry. It does not establish that any GHK formulation safely redistributes copper throughout the body or improves a disease outcome.
Frequently asked questions
Was histidine included in some experiments?
Yes.
Were multiple chemical species identified?
Yes.
Was competition with albumin examined?
Yes, under defined laboratory conditions.
Do equal-concentration experiments reproduce every biological setting?
No.
Is total copper identical to intact copper–GHK?
No.
Does binding establish tissue delivery?
No.
Was clinical benefit demonstrated?
No.